|
Treating Mouth Sores in Pediatric Chemotherapy Patients
Untitled Document
Name of the Trial
Randomized Study of Traumeel® S for the Prevention and Treatment of Mucositis
in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation (COG-ACCL0331).
See the protocol summary 4.
Principal Investigators
Dr. Susan Sencer and Dr. Indira Sahdev of the Children's Oncology Group.
 |
Dr. Susan Sencer
Principal Investigator |
Why This Trial Is Important
Chemotherapy drugs for cancer may produce a number of side effects. These side
effects can prevent or delay further treatment and may lead to serious complications,
including infection and death. Therefore, researchers are eager to find effective
ways to prevent or lessen side effects from chemotherapy.
Mucositis (sores and ulcers in the lining of the mouth) is a common side effect
of chemotherapy. This trial is testing a homeopathic preparation, called Traumeel®
S, as a treatment for mucositis in young patients undergoing chemotherapy in
preparation for stem cell transplantation. High-dose
chemotherapy and stem cell
transplantation are frequently used in treating pediatric patients with leukemia
or solid tumors. Traumeel® S is a homeopathic remedy containing certain
minerals and extracts from 12 different types of plants.
"An earlier study of Traumeel® S conducted in Israel showed a significant
reduction in mucositis among young patients undergoing stem cell transplantation,"
said Dr. Sencer. "With this trial, we hope to confirm those findings and
therefore determine whether Traumeel® S is an effective treatment for
chemotherapy-related
mucositis.
"There is a great deal of interest in complementary and alternative medicines
among the public and studies have shown that our patients are using them,"
added Dr. Sencer. "We feel we have a responsibility to test these methods
as rigorously as we would test any other intervention."
Contact Information
This trial is no longer enrolling new patients. To find other supportive care
clinical trials, search the NCI database of clinical
trials 1 or call the NCI Cancer Information Service at 1-800-4-CANCER
(1-800-422-6237). The call is toll free and confidential.
|